-
1
المساهمون: Malmström, Per, Creator
المصدر: The Lancet. Oncology. 19(1):27-39
مصطلحات موضوعية: Adult, Antineoplastic Agents/administration & dosage, Breast Neoplasms/drug therapy, Chemotherapy, Adjuvant, Disease Progression, Female, Humans, Mastectomy, Segmental, Middle Aged, Neoadjuvant Therapy/adverse effects, Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasm Staging, Randomized Controlled Trials as Topic, Risk Factors, Time Factors, Treatment Outcome, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology
-
2
المؤلفون: Emil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, Sara K. Elbæk, Sia V. Lindskrog, Ann Taber, Tine G. Andreasen, Trine Strandgaard, Michael Knudsen, Philippe Lamy, Mads Agerbæk, Jørgen B. Jensen, Lars Dyrskjøt
المصدر: Christensen, E, Nordentoft, I, Birkenkamp-Demtroder, K, Elbæk, S K, Lindskrog, S V, Taber, A, Andreasen, T G, Strandgaard, T, Knudsen, M, Lamy, P, Agerbæk, M, Jensen, J B & Dyrskjøt, L 2023, ' Cell-free urine-and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer ', Clinical Cancer Research, vol. 29, no. 8, pp. 1582–1591 . https://doi.org/10.1158/1078-0432.CCR-22-3250
مصطلحات موضوعية: Muscles/pathology, Cancer Research, Urinary Bladder Neoplasms/drug therapy, Oncology, Chemotherapy, Adjuvant, DNA Mutational Analysis, Neoadjuvant Therapy/adverse effects, Humans, Neoplasm Invasiveness/pathology, Cystectomy, Retrospective Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf1f58ca57cdc96542ccdf2f65dc41d
https://doi.org/10.1158/1078-0432.ccr-22-3250 -
3
المؤلفون: Pritchard-Jones, Kathy, Bergeron, Christophe, de Camargo, Beatriz, van den Heuvel-Eibrink, Marry M, Acha, Tomas, Godzinski, Jan, Oldenburger, Foppe, Boccon-Gibod, Liliane, Leuschner, Ivo, Vujanic, Gordan, Sandstedt, Bengt, de Kraker, Jan, van Tinteren, Harm, Graf, Norbert
المساهمون: Øra, Ingrid, Creator
المصدر: The Lancet. 386(9999):64-1156
مصطلحات موضوعية: Adolescent, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Chemotherapy, Adjuvant/adverse effects, Child, Preschool, Dactinomycin/administration & dosage, Doxorubicin/administration & dosage, Female, Humans, Infant, Kaplan-Meier Estimate, Kidney Neoplasms/drug therapy, Male, Neoadjuvant Therapy/adverse effects, Neoplasm Staging, Nephrectomy, Treatment Outcome, Vincristine/administration & dosage, Wilms Tumor/drug therapy, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology
-
4
المؤلفون: Versteijne, E., Suker, M., Groen, J.V., Besselink, M.G., Bonsing, B.A., Bosscha, K., Busch, O.R., Hingh, I.H.J.T. de, Jong, K.P. de, Molenaar, I.Q., Santvoort, H.C. van, Verkooijen, H.M., Eijck, C.H. van, Tienhoven, G. van, Dutch Pancreatic Canc Grp
المساهمون: Radiotherapy, Surgery, CCA - Imaging and biomarkers, CCA - Cancer Treatment and Quality of Life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiation Oncology, CCA - Treatment and quality of life
المصدر: Annals of surgery, 275(5), 972-978. Lippincott Williams and Wilkins
Annals of Surgery. Lippincott Williams and Wilkins
Annals of Surgery, 275(5), 972-978. LIPPINCOTT WILLIAMS & WILKINSمصطلحات موضوعية: medicine.medical_specialty, MEDLINE, Resection, law.invention, External validity, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Borderline resectable, law, Pancreatic Neoplasms/drug therapy, Pancreatic cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, external validity, Humans, PREOPANC trial, eligible nonrandomized patients, business.industry, Neoadjuvant Therapy/adverse effects, Chemoradiotherapy, medicine.disease, Neoadjuvant Therapy, Pancreatic Neoplasms, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Surgery, Observational study, business, Neoadjuvant chemoradiotherapy
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931c8664c6f7e624b5515d4d10008b18
https://doi.org/10.1097/sla.0000000000004364 -
5رسالة جامعية
المؤلفون: Klevebro, Fredrik
مصطلحات موضوعية: Esophageal Neoplasms -- mortality, Esophageal Neoplasms -- therapy, Esophagogastric Junction -- pathology, Neoadjuvant Therapy -- adverse effects, Chemoradiotherapy, Adjuvant -- adverse effects, Anastomosis, Surgical -- adverse effects
Degree: Diss. (sammanfattning) Stockholm : Karolinska Institutet, 2016
-
6رسالة جامعية
المؤلفون: Lund, Mikael
مصطلحات موضوعية: Esophageal Neoplasms -- surgery, Neoadjuvant Therapy -- adverse effects, One-Lung Ventilation, Myocardial Reperfusion Injury -- etiology, Thoracic Surgical Procedures -- adverse effects
Degree: Diss. (sammanfattning) Stockholm : Karolinska Institutet, 2016
-
7
المؤلفون: Curioni-Fontecedro, Alessandra, Perentes, Jean Yannis, Gelpke, Hans, Xyrafas, Alexandros, Bouchaab, Hasna, Mach, Nicolas, Matzinger, Oscar, Stojcheva, Nina, Frueh, Martin, Weder, Walter, Cathomas, Richard, Gargiulo, Piera, Bubendorf, Lukas, Pless, Miklos, Betticher, Daniel, Peters, Solange, Swiss Group of Clinical Cancer Research (SAKK)
المساهمون: Swiss Group of Clinical Cancer Research (SAKK), University of Zurich, Curioni-Fontecedro, Alessandra
المصدر: British journal of cancer, vol. 120, no. 10, pp. 968-974
British Journal of Cancer, Vol. 120, No 10 (2019) pp. 968-974
British Journal of Cancerمصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, 10255 Clinic for Thoracic Surgery, medicine.medical_treatment, Cetuximab, 610 Medicine & health, Docetaxel, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Aged, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/pathology, Carcinoma, Non-Small-Cell Lung/radiotherapy, Carcinoma, Non-Small-Cell Lung/surgery, Cetuximab/administration & dosage, Cetuximab/adverse effects, Chemoradiotherapy, Cisplatin/administration & dosage, Cisplatin/adverse effects, Docetaxel/administration & dosage, Docetaxel/adverse effects, Female, Humans, Middle Aged, Neoadjuvant Therapy/adverse effects, Neoplasm Staging, Progression-Free Survival, medicine, Clinical endpoint, 1306 Cancer Research, Lung cancer, neoplasms, Cisplatin, ddc:616, Chemotherapy, business.industry, medicine.disease, Neoadjuvant Therapy, Radiation therapy, 030220 oncology & carcinogenesis, Concomitant, Surgical oncology, 10032 Clinic for Oncology and Hematology, 2730 Oncology, business, Non-small-cell lung cancer, medicine.drug
وصف الملف: application/pdf; 41416_2019_Article_447.pdf - application/pdf
-
8
المؤلفون: Kathryn Pritchard-Jones, Anne-Sophie DEFACHELLES, Sucheta Vaidya, Gustaf Ljungman, Norbert Graf, Marc Ansari, Gordan Vujanic, Ricardo López Almaraz, Pedro Zubizarreta, Jan Godziński, Pamela Kearns, Anna Llort, Beatriz De Camargo, Leo Kager, Harm Van Tinteren, Ingrid Øra
المساهمون: University of Zurich, Pritchard-Jones, Kathy, CCA -Cancer Center Amsterdam, Radiotherapy, Paediatric Oncology, Oncogenomics
المصدر: Pritchard-Jones, K, Bergeron, C, de Camargo, B, van den Heuvel-Eibrink, M M, Acha, T, Godzinski, J, Oldenburger, F, Boccon-Gibod, L, Leuschner, I, Vujanic, G, Sandstedt, B, de Kraker, J, van Tinteren, H, Graf, N & SIOP Renal Tumours Study Group 2015, ' Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001) : an open-label, non-inferiority, randomised controlled trial ', Lancet, vol. 386, no. 9999, pp. 1156-1164 . https://doi.org/10.1016/S0140-6736(14)62395-3
Lancet, 386(9999), 1156-1164. Elsevier Limited
The Lancet, Vol. 386, No 9999 (2015) pp. 1156-64مصطلحات موضوعية: Male, medicine.medical_specialty, Vincristine, Adolescent, medicine.medical_treatment, Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use, 610 Medicine & health, Kaplan-Meier Estimate, 2700 General Medicine, Nephrectomy, Wilms Tumor, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Doxorubicin, Child, Kidney Neoplasms/drug therapy/pathology/surgery, Neoplasm Staging, Neoadjuvant Therapy/adverse effects/methods, Chemotherapy, Cardiotoxicity, ddc:618, Intention-to-treat analysis, business.industry, Standard treatment, Infant, Wilms' tumor, General Medicine, Doxorubicin/administration & dosage/adverse effects, medicine.disease, Kidney Neoplasms, Neoadjuvant Therapy, Surgery, Regimen, Treatment Outcome, Wilms Tumor/drug therapy/pathology/surgery, Chemotherapy, Adjuvant, 10036 Medical Clinic, Child, Preschool, Dactinomycin, Chemotherapy, Adjuvant/adverse effects/methods, Dactinomycin/administration & dosage/adverse effects, Female, Vincristine/administration & dosage/adverse effects, business, medicine.drug
وصف الملف: 1-s2.0-S0140673614623953-main.pdf - application/pdf
-
9
المؤلفون: Marinus A. Paul, Cornelis G. Vos, Janine Halmans, Ramon R. Gorter, Koen J. Hartemink, Jan W.A. Oosterhuis
المساهمون: Surgery, Cardio-thoracic surgery, CCA - Quality of life, ICaR - Ischemia and repair, Paediatric Surgery, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Reproduction & Development, Cardiothoracic Surgery
المصدر: Gorter, R R, Vos, C G, Halmans, J, Hartemink, K J, Paul, M A & Oosterhuis, J W A 2013, ' Evaluation of arm function and quality of life after trimodality treatment for superior sulcus tumours ', Interactive Cardiovascular and Thoracic Surgery, vol. 16, no. 1, pp. 44-48 . https://doi.org/10.1093/icvts/ivs394
Interactive Cardiovascular and Thoracic Surgery, 16(1), 44-48. European Association for Cardio-Thoracic Surgery
Interactive cardiovascular and thoracic surgery, 16(1), 44-8. Oxford University Pressمصطلحات موضوعية: Male, Time Factors, medicine.medical_treatment, Functional Laterality, Disability Evaluation, Quality of life, Surveys and Questionnaires, Adjuvant/adverse effects, Neoadjuvant therapy, Pain Measurement, Pain, Postoperative, medicine.diagnostic_test, Neoadjuvant Therapy/adverse effects, Chemoradiotherapy, Chemoradiotherapy, Adjuvant/adverse effects, Sulcus, Middle Aged, Neoadjuvant Therapy, Biomechanical Phenomena, medicine.anatomical_structure, Treatment Outcome, Cardiothoracic surgery, Female, Cardiology and Cardiovascular Medicine, Range of motion, Pancoast Syndrome/diagnosis, Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Upper Extremity/physiopathology, Pain, Physical examination, Upper Extremity, medicine, Humans, Postoperative/diagnosis, Survival rate, Physical Examination, Aged, business.industry, Pancoast Syndrome, Chemoradiotherapy, Adjuvant, Original Articles, Recovery of Function, Surgery, Pain, Postoperative/diagnosis, Quality of Life, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074f3545d75363e292a0536dd5de12ef
https://research.vumc.nl/en/publications/f8c4abe3-95f4-440e-af1a-a47fd3d79475 -
10مورد إلكتروني
المؤلفون: Eriksson, Victoria, Holmlund, Jennie, Wiberg, Erik, Johansson, Markus, Huge, Ylva, Alamdari, Farhood, Svensson, Johan, Aljabery, Firas, Sherif, Amir
مصطلحات الفهرس: Bladder cancer; neoadjuvant therapy; adverse effects; cystectomy, Urology and Nephrology, Urologi och njurmedicin, Article in journal, info:eu-repo/semantics/article, text
URL:
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-187514
2022
Translational Andrology and Urology, 2223-4683, 2022
Full Text via ClinicalKey 
Find this article in full text from Springer Verlag.